Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01327885 |
|---|---|
| Brief Title: | Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma |
| First Submitted : | March 31, 2011 |
| First Submitted that Met QC Criteria : | April 1, 2011 |
| First Posted : | April 4, 2011 (Estimate) |
| Results First Submitted : | January 6, 2017 |
| Results First Submitted that Met QC Criteria : | January 6, 2017 |
| Results First Posted : | February 28, 2017 |
| Last Update Submitted that Met QC Criteria : | July 14, 2020 |
| Last Update Posted : | July 29, 2020 |